Evolus, Inc. (EOLS)
Market Cap | 667.43M |
Revenue (ttm) | 219.70M |
Net Income (ttm) | -60.00M |
Shares Out | 62.61M |
EPS (ttm) | -1.04 |
PE Ratio | n/a |
Forward PE | n/a |
Dividend | n/a |
Ex-Dividend Date | n/a |
Volume | 362,022 |
Open | 11.00 |
Previous Close | 11.08 |
Day's Range | 10.63 - 11.00 |
52-Week Range | 7.07 - 15.43 |
Beta | 1.32 |
Analysts | Strong Buy |
Price Target | 22.60 (+112.01%) |
Earnings Date | Jul 31, 2024 |
About EOLS
Evolus, Inc., a performance beauty company, focuses on delivering products in the cash-pay aesthetic market in the United States, Canada, and Europe. The company offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults; and Nuceiva, for the temporary improvement in the appearance of moderate to severe vertical lines between the eyebrows seen at maximum frown. It also provides dermal filler products under the Estyme and... [Read more]
Full Company ProfileFinancial Performance
In 2023, Evolus's revenue was $202.09 million, an increase of 35.98% compared to the previous year's $148.62 million. Losses were -$61.69 million, -17.10% less than in 2022.
Financial StatementsAnalyst Forecast
According to 6 analysts, the average rating for EOLS stock is "Strong Buy." The 12-month stock price forecast is $22.6, which is an increase of 112.01% from the latest price.
News
![](https://cdn.snapi.dev/images/v1/9/j/press20-2504820.jpg)
Evolus Announces Appointment of Albert G. White III to Board of Directors
NEWPORT BEACH, Calif.--(BUSINESS WIRE)--Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today announced the appointment of...
![](https://cdn.snapi.dev/images/v1/o/a/press1-2492587.jpg)
Evolus Announces Submission of Premarket Approval Application to the U.S. Food and Drug Administration for First Two Evolysse™ Dermal Filler Products
NEWPORT BEACH, Calif.--(BUSINESS WIRE)--Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today announced that it has submit...
![](https://cdn.snapi.dev/images/v1/o/t/press12-2475389.jpg)
Evolus Broadens International Presence with Launch of Nuceiva® (botulinum toxin type A) in Spain
NEWPORT BEACH, Calif.--(BUSINESS WIRE)--Evolus, Inc. (NASDAQ: EOLS), a performance beauty company focused on building an aesthetic portfolio, has commercially launched Nuceiva® (botulinum toxin type A...
![](https://cdn.snapi.dev/images/v1/d/b/press10-2469315.jpg)
Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
NEWPORT BEACH, Calif.--(BUSINESS WIRE)--Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today reported the grant of non-qu...
![](https://cdn.snapi.dev/images/v1/m/y/press18-2439565.jpg)
Evolus Announces Positive Data from Pivotal Trial for First Two Evolysse™ Dermal Filler Products at 2024 SCALE Meeting
NEWPORT BEACH, Calif.--(BUSINESS WIRE)--Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today announced positive topline r...
![](https://cdn.snapi.dev/images/v1/t/s/press9-2431964.jpg)
Evolus Celebrates Fifth Anniversary of Launching its Flagship Product Jeuveau® at the Women's Wear Daily Beauty CEO Summit
NEWPORT BEACH, Calif.--(BUSINESS WIRE)--Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today announced its participation ...
![](https://cdn.snapi.dev/images/v1/j/b/press2-2424058.jpg)
Evolus' Sandra Beaver Named Orange County Business Journal's Public Company CFO of the Year
NEWPORT BEACH, Calif.--(BUSINESS WIRE)--Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today announced that its Chief Fin...
![](https://cdn.snapi.dev/images/v1/7/q/press16-2416201.jpg)
Evolus Reports First Quarter 2024 Results and Provides Business Update
NEWPORT BEACH, Calif.--(BUSINESS WIRE)--Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today reported financial results f...
![](https://cdn.snapi.dev/images/v1/z/8/conf14-2386776.jpg)
Evolus to Report First Quarter Financial Results on May 7, 2024
NEWPORT BEACH, Calif.--(BUSINESS WIRE)--Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today announced that it will repor...
![](https://cdn.snapi.dev/images/v1/k/j/press9-2376913.jpg)
Evolus Announces Publication of Safety and Duration Data from Phase 2 Study for “Extra-Strength” 40U Formulation of Jeuveau®
NEWPORT BEACH, Calif.--(BUSINESS WIRE)--Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today announced that the Aesthetic...
![](https://cdn.snapi.dev/images/v1/r/x/press17-2341623.jpg)
Evolus to Participate in the 23rd Annual Needham Virtual Healthcare Conference
NEWPORT BEACH, Calif.--(BUSINESS WIRE)--Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a focus on building an aesthetic portfolio, today announced that members of its management team w...
![](https://cdn.snapi.dev/images/v1/u/e/press14-2317427.jpg)
Evolus Announces Pricing of $50.0 Million Underwritten Offering of Common Stock
NEWPORT BEACH, Calif.--(BUSINESS WIRE)--Evolus, Inc. (Nasdaq: EOLS) announced today the pricing of its underwritten offering of 3,554,000 shares of its common stock at a underwritten offering price of...
![](https://cdn.snapi.dev/images/v1/k/q/press7-2314207.jpg)
Evolus Reports Record Fourth Quarter and Full Year 2023 Financial Results; Reaffirms 2024 Guidance
NEWPORT BEACH, Calif.--(BUSINESS WIRE)--Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a customer-centric approach focused on delivering breakthrough products, today announced its fina...
![](https://cdn.snapi.dev/images/v1/u/x/press5-2303504.jpg)
Evolus Announces Results from European Head-to-Head Filler Trial
NEWPORT BEACH, Calif.--(BUSINESS WIRE)--Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today announced that it will provi...
![](https://cdn.snapi.dev/images/v1/c/o/conf15-2295810.jpg)
Evolus to Participate in Upcoming Leerink Partners and Barclays Investor Conferences
NEWPORT BEACH, Calif.--(BUSINESS WIRE)--Evolus to Participate in Upcoming Leerink Partners and Barclays Investor Conferences.
![](https://cdn.snapi.dev/images/v1/g/g/conf12-2289877.jpg)
Evolus to Report Fourth Quarter and Year End 2023 Results and Provide Business Update on March 7, 2024
NEWPORT BEACH, Calif.--(BUSINESS WIRE)--To participate in the conference call, dial (877) 407-6184 or (201) 389-0877 or join the webcast on the Investor Relations page of the Evolus website.
![](https://cdn.snapi.dev/images/v1/o/d/press10-2231655.jpg)
Evolus Announces Preliminary Unaudited Fourth Quarter and Full-Year 2023 Net Revenue, Achieving Record Results and Exceeding Expectations; Issues 2024 Guidance
NEWPORT BEACH, Calif.--(BUSINESS WIRE)--Evolus Announces Preliminary Unaudited Fourth Quarter and Full-Year 2023 Net Revenue, Achieving Record Results and Exceeding Expectations.
![](https://cdn.snapi.dev/images/v1/w/a/press10-2217284.jpg)
Evolus Announces the Appointment of Nareg Sagherian to Vice President, Head of Global Investor Relations and Corporate Communications
NEWPORT BEACH, Calif.--(BUSINESS WIRE)--Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today announced that Nareg Sagheri...
![](https://cdn.snapi.dev/images/v1/s/n/press1-2203366.jpg)
Evolus Enters into Licensing Agreement with Symatese to Exclusively Distribute Next-Generation Dermal Fillers in Europe
NEWPORT BEACH, Calif.--(BUSINESS WIRE)--Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a focus on building an aesthetic portfolio, today announced it has entered into a definitive agre...
![](https://cdn.snapi.dev/images/v1/s/r/press9-2145357.jpg)
Evolus Reports Record Third Quarter 2023 Financial Results and Phase II Data for Extra-Strength 40U Formulation of Jeuveau®
NEWPORT BEACH, Calif.--(BUSINESS WIRE)--Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today reported financial results f...
![](https://cdn.snapi.dev/images/v1/t/h/press16-2141482.jpg)
“Extra-Strength” 40U Formulation of Jeuveau® Demonstrates Effects Lasting 26 Weeks in Phase II Data Presented at 2023 ASDS Annual Meeting
NEWPORT BEACH, Calif.--(BUSINESS WIRE)--Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, announced results from the Phase 2...
![](https://cdn.snapi.dev/images/v1/0/u/conf5-2132877.jpg)
Evolus to Participate in November Investor Conferences
NEWPORT BEACH, Calif.--(BUSINESS WIRE)--Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today announced that members of it...
![](https://cdn.snapi.dev/images/v1/w/8/press6-2119680.jpg)
Final Phase 2 Data Evaluating 40U Dose of PrabotulinumtoxinA-xvfs to be Presented at 2023 ASDS Annual Meeting
NEWPORT BEACH, Calif.--(BUSINESS WIRE)--Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today announced that Sue Ellen Cox...
![](https://cdn.snapi.dev/images/v1/2/u/conf4-2119679.jpg)
Evolus to Report Third Quarter 2023 Results
NEWPORT BEACH, Calif.--(BUSINESS WIRE)--Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today announced that it will repor...
![](https://cdn.snapi.dev/images/v1/4/p/press4-2041102.jpg)
Evolus to Participate in September Conferences
NEWPORT BEACH, Calif.--(BUSINESS WIRE)--Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today announced that members of it...